Role of pharmacokinetics in the outcome of infections
Open Access
- 1 March 1988
- journal article
- review article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 32 (3) , 289-297
- https://doi.org/10.1128/aac.32.3.289
Abstract
No abstract availableThis publication has 42 references indexed in Scilit:
- Comparative activities of piperacillin, ceftazidime, and amikacin, alone and in all possible combinations, against experimental Pseudomonas aeruginosa infections in neutropenic ratsAntimicrobial Agents and Chemotherapy, 1985
- The relevance of pharmacokinetics to in-vitro models: protein binding--does it matter?Journal of Antimicrobial Chemotherapy, 1985
- Multiple-dose pharmacokinetics of imipenem-cilastatinAntimicrobial Agents and Chemotherapy, 1984
- Association of aminoglycoside plasma levels with therapeutic outcome in gram-negative pneumoniaThe American Journal of Medicine, 1984
- Significance of serum bactericidal activity in gram-negative bacillary bacteremia in patients with and without granulocytopeniaThe American Journal of Medicine, 1984
- The Association of Aminoglycoside Plasma Levels with Mortality in Patients with Gram-Negative BacteremiaThe Journal of Infectious Diseases, 1984
- Selection of Aminoglycoside-Resistant Variants of Pseudomonas aeruginosa in an in Vivo ModelThe Journal of Infectious Diseases, 1982
- Postantibiotic Suppression of Bacterial GrowthClinical Infectious Diseases, 1981
- The Influence of Protein Binding upon Tissue Fluid Levels of Six -Lactam AntibioticsThe Journal of Infectious Diseases, 1980
- A Randomized Comparative Trial of Three Aminoglycosides—Comparison of Continuous Infusions of Gentamicin, Aaikacin and Sisomicin Combined with Carbenicillin in the Treatment of Infections in Neutropenic Patients with MalignanciesMedicine, 1979